The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer
Authors
Keywords
-
Journal
IMMUNOLOGICAL REVIEWS
Volume 276, Issue 1, Pages 145-164
Publisher
Wiley
Online
2017-03-04
DOI
10.1111/imr.12527
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SIRP -Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells
- (2016) E. C. Piccione et al. CLINICAL CANCER RESEARCH
- Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation
- (2016) José Alexandre Ferreira et al. DRUG RESISTANCE UPDATES
- The CD47 “don't eat me signal” is highly expressed in human ovarian cancer
- (2016) R.M. Brightwell et al. GYNECOLOGIC ONCOLOGY
- Immune checkpoint blockade: Which switches to hit and how much?
- (2016) Hanke L. Matlung et al. IMMUNOLOGY LETTERS
- Immune checkpoint inhibitors side effects and management
- (2016) Hampig Raphael Kourie et al. Immunotherapy
- CD47-SIRPα Interactions Regulate Macrophage Uptake of Plasmodium falciparum-Infected Erythrocytes and Clearance of MalariaIn Vivo
- (2016) Kodjo Ayi et al. INFECTION AND IMMUNITY
- Divergent modulation of normal and neoplastic stem cells by thrombospondin-1 and CD47 signaling
- (2016) Sukhbir Kaur et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
- (2016) Louis Fehrenbacher et al. LANCET
- CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis
- (2016) Yoko Kojima et al. NATURE
- Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors
- (2016) Geoffrey Wayne Krampitz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cd47-Sirpα interaction and IL-10 constrain inflammation-induced macrophage phagocytosis of healthy self-cells
- (2016) Zhen Bian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Durable antitumor responses to CD47 blockade require adaptive immune stimulation
- (2016) Jonathan T. Sockolosky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MYC regulates the antitumor immune response through CD47 and PD-L1
- (2016) S. C. Casey et al. SCIENCE
- PO-15 - Antiangiogenic small molecule ligands of FGF2 derived from the endogenous inhibitor thrombospondin-1
- (2016) D. Pinessi et al. THROMBOSIS RESEARCH
- Upregulation of CD47 in Regulatory T Cells in Atopic Dermatitis
- (2016) Nara Lee et al. YONSEI MEDICAL JOURNAL
- CD47 deficiency in tumor stroma promotes tumor progression by enhancing angiogenesis
- (2016) Lu Gao et al. Oncotarget
- Inhibition of SIRPα in dendritic cells potentiates potent antitumor immunity
- (2016) Qiong Liu et al. OncoImmunology
- Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo
- (2016) Michael Zhang et al. PLoS One
- CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer
- (2016) Hui Zhao et al. Scientific Reports
- FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis
- (2015) Rony Dahan et al. CANCER CELL
- Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma
- (2015) Zhenyu Xiao et al. CANCER LETTERS
- Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect
- (2015) David J. DiLillo et al. CELL
- Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
- (2015) M. Cioffi et al. CLINICAL CANCER RESEARCH
- Ara-C and anti-CD47 antibody combination therapy eliminates acute monocytic leukemia THP-1 cells in vivo and in vitro
- (2015) Y. Wang et al. GENETICS AND MOLECULAR RESEARCH
- Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice
- (2015) Jessica Lo et al. HEPATOLOGY
- Splenic Dendritic Cells Survey Red Blood Cells for Missing Self-CD47 to Trigger Adaptive Immune Responses
- (2015) Tangsheng Yi et al. IMMUNITY
- Mouse and human FcR effector functions
- (2015) Pierre Bruhns et al. IMMUNOLOGICAL REVIEWS
- Cleavage of Signal Regulatory Protein α (SIRPα) Enhances Inflammatory Signaling
- (2015) James D. Londino et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- “Velcro” Engineering of High Affinity CD47 Ectodomain as Signal Regulatory Protein α (SIRPα) Antagonists That Enhance Antibody-dependent Cellular Phagocytosis
- (2015) Chia Chi M. Ho et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CD47 deficiency ameliorates autoimmune nephritis in Faslpr mice by suppressing IgG autoantibody production
- (2015) Lei Shi et al. JOURNAL OF PATHOLOGY
- Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
- (2015) Jeffrey S Weber et al. LANCET ONCOLOGY
- Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
- (2015) Naiyer A Rizvi et al. LANCET ONCOLOGY
- Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
- (2015) Alexander M M Eggermont et al. LANCET ONCOLOGY
- A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells
- (2015) Emily C Piccione et al. mAbs
- CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
- (2015) Xiaojuan Liu et al. NATURE MEDICINE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD47 Promotes Protective Innate and Adaptive Immunity in a Mouse Model of Disseminated Candidiasis
- (2015) Dhammika H. M. L. P. Navarathna et al. PLoS One
- Regulation of Phagocyte Migration by Signal Regulatory Protein-Alpha Signaling
- (2015) Julian Alvarez-Zarate et al. PLoS One
- HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
- (2015) Huimin Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- CD47 blockade inhibits tumor progression human osteosarcoma in xenograft models
- (2015) Ji-Feng Xu et al. Oncotarget
- CD47 Agonist Peptides Induce Programmed Cell Death in Refractory Chronic Lymphocytic Leukemia B Cells via PLCγ1 Activation: Evidence from Mice and Humans
- (2015) Ana-Carolina Martinez-Torres et al. PLOS MEDICINE
- Fc-Receptor Interactions Regulate Both Cytotoxic and Immunomodulatory Therapeutic Antibody Effector Functions
- (2015) D. J. DiLillo et al. Cancer Immunology Research
- CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer
- (2015) Kazumichi Yoshida et al. Cancer Medicine
- Original insights on thrombospondin-1-related antireceptor strategies in cancer
- (2015) Albin Jeanne et al. Frontiers in Pharmacology
- Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential
- (2015) Jie Liu et al. PLoS One
- Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma
- (2014) Hiroki Goto et al. EUROPEAN JOURNAL OF CANCER
- Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma
- (2014) Terence Kin-Wah Lee et al. HEPATOLOGY
- Signal-regulatory proteinαfrom the NOD mouse binds human CD47 with an exceptionally high affinity - implications for engraftment of human cells
- (2014) Lai Shan Kwong et al. IMMUNOLOGY
- Polymorphisms in the Human Inhibitory Signal-regulatory Protein α Do Not Affect Binding to Its Ligand CD47
- (2014) Deborah Hatherley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Polymorphism in the Innate Immune Receptor SIRPα Controls CD47 Binding and Autoimmunity in the Nonobese Diabetic Mouse
- (2014) Andrea Sut Ling Wong et al. JOURNAL OF IMMUNOLOGY
- The Interaction Between Signal Regulatory Protein Alpha (SIRPα) and CD47: Structure, Function, and Therapeutic Target
- (2013) A. Neil Barclay et al. Annual Review of Immunology
- Neutrophils mediate antibody-induced antitumor effects in mice
- (2013) M. Albanesi et al. BLOOD
- The current spectrum of infection in cancer patients with chemotherapy related neutropenia
- (2013) Lior Nesher et al. INFECTION
- Sterile-α- and Armadillo Motif-Containing Protein Inhibits the TRIF-Dependent Downregulation of Signal Regulatory Protein α To Interfere with Intracellular Bacterial Elimination in Burkholderia pseudomallei-Infected Mouse Macrophages
- (2013) Pankaj Baral et al. INFECTION AND IMMUNITY
- On the Mechanism and Benefit of siRNA-mediated Targeting of CD47 in Cancer
- (2013) Xiwen Zhao et al. MOLECULAR THERAPY
- Reply to “On the Mechanism and Benefit of siRNA-mediated Targeting of CD47 in Cancer”
- (2013) Yuhua Wang et al. MOLECULAR THERAPY
- Intravenous Delivery of siRNA Targeting CD47 Effectively Inhibits Melanoma Tumor Growth and Lung Metastasis
- (2013) Yuhua Wang et al. MOLECULAR THERAPY
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engagement of SIRPα Inhibits Growth and Induces Programmed Cell Death in Acute Myeloid Leukemia Cells
- (2013) Mahban Irandoust et al. PLoS One
- Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
- (2013) D. Tseng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Engineered SIRP Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
- (2013) K. Weiskopf et al. SCIENCE
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- Inflammation-induced proteolytic processing of the SIRPα cytoplasmic ITIM in neutrophils propagates a proinflammatory state
- (2013) Ke Zen et al. Nature Communications
- Thrombospondin-1 Regulates Blood Flow via CD47 Receptor–Mediated Activation of NADPH Oxidase 1
- (2012) Gábor Csányi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Is targeting of CD47-SIRP enough for treating hematopoietic malignancy?
- (2012) X. W. Zhao et al. BLOOD
- Response: mechanisms of targeting CD47-SIRP in hematologic malignancies
- (2012) M. P. Chao et al. BLOOD
- Engulfment of hematopoietic stem cells caused by down-regulation of CD47 is critical in the pathogenesis of hemophagocytic lymphohistiocytosis
- (2012) T. Kuriyama et al. BLOOD
- The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
- (2012) Donald C. McMillan CANCER TREATMENT REVIEWS
- High reproducible ADCC analysis revealed a competitive relation between ADCC and CDC and differences between FcγRllla polymorphism
- (2012) Yuji Mishima et al. INTERNATIONAL IMMUNOLOGY
- Surfactant Protein D (Sp-D) Binds to Membrane-proximal Domain (D3) of Signal Regulatory Protein α (SIRPα), a Site Distant from Binding Domain of CD47, while Also Binding to Analogous Region on Signal Regulatory Protein β (SIRPβ)
- (2012) Bénédicte Fournier et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice
- (2012) May H. Han et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts
- (2012) Alexandre P.A. Theocharides et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD47 Deficiency Does Not Impede Polymorphonuclear Neutrophil Transmigration but Attenuates Granulopoiesis at the Postacute Stage of Colitis
- (2012) Z. Bian et al. JOURNAL OF IMMUNOLOGY
- CD47high Expression on CD4 Effectors Identifies Functional Long-Lived Memory T Cell Progenitors
- (2012) V. Q. Van et al. JOURNAL OF IMMUNOLOGY
- Increased Susceptibility to Salmonella Infection in Signal Regulatory Protein -Deficient Mice
- (2012) L.-X. Li et al. JOURNAL OF IMMUNOLOGY
- Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells
- (2012) D Kim et al. LEUKEMIA
- Reply to Soto-Pantoja et al. and Zhao et al.: Targeting CD47 on human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibitory signaling through signal regulatory protein- is not sufficient to explain the antitumor activities of CD47 antibodies
- (2012) D. R. Soto-Pantoja et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- On the mechanism of CD47 targeting in cancer
- (2012) X. W. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma
- (2012) B. Edris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SIRPα Controls the Activity of the Phagocyte NADPH Oxidase by Restricting the Expression of gp91phox
- (2012) Ellen M. van Beek et al. Cell Reports
- Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy
- (2011) M. P. Chao et al. BLOOD
- CD47-signal regulatory protein- (SIRP ) interactions form a barrier for antibody-mediated tumor cell destruction
- (2011) X. W. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Requirement of SIRPα for protective immunity against Leishmania major
- (2010) Naoko Morimoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Regulation by SIRP of dendritic cell homeostasis in lymphoid tissues
- (2010) Y. Saito et al. BLOOD
- Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies
- (2010) Markus Münz et al. Cancer Cell International
- Therapeutic Antibody Targeting of CD47 Eliminates Human Acute Lymphoblastic Leukemia
- (2010) Mark P. Chao et al. CANCER RESEARCH
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
- (2010) Mark P. Chao et al. CELL
- Targeting SIRP-α protects from type 2-driven allergic airway inflammation
- (2010) Marianne Raymond et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- AMPKα1 Deletion Shortens Erythrocyte Life Span in Mice
- (2010) Shaobin Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models
- (2010) William M. Siders et al. LEUKEMIA & LYMPHOMA
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47
- (2010) M. P. Chao et al. Science Translational Medicine
- CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
- (2009) Siddhartha Jaiswal et al. CELL
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels
- (2009) Ulrike Lorenz IMMUNOLOGICAL REVIEWS
- Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model
- (2009) Yanping Hu et al. IMMUNOLOGY
- A role for CD47 in the development of experimental colitis mediated by SIRPα+CD103−dendritic cells
- (2009) Genevieve Fortin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage
- (2009) Tanja Schneider-Merck et al. JOURNAL OF IMMUNOLOGY
- Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells
- (2009) K. S. Chan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Surfactant Proteins A and D Suppress Alveolar Macrophage Phagocytosis via Interaction with SIRPα
- (2008) William J. Janssen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Resistance to collagen-induced arthritis in SHPS-1 mutant mice
- (2008) Chie Okuzawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Endothelial CD47 interaction with SIRP is required for human T-cell transendothelial migration under shear flow conditions in vitro
- (2008) M. Stefanidakis et al. BLOOD
- Specificity and affinity of human Fc receptors and their polymorphic variants for human IgG subclasses
- (2008) P. Bruhns et al. BLOOD
- CD47 in the Immune Response: Role of Thrombospondin and SIRP-α Reverse Signaling
- (2008) Marika Sarfati et al. CURRENT DRUG TARGETS
- Differential Interactions of Thrombospondin-1, -2, and -4 with CD47 and Effects on cGMP Signaling and Ischemic Injury Responses
- (2008) Jeff S. Isenberg et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells
- (2008) Richard K. Tsai et al. JOURNAL OF CELL BIOLOGY
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
- Paired Receptor Specificity Explained by Structures of Signal Regulatory Proteins Alone and Complexed with CD47
- (2008) Deborah Hatherley et al. MOLECULAR CELL
- Evolution of the Ly49 and Nkrp1 recognition systems
- (2008) James R. Carlyle et al. SEMINARS IN IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now